Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

A research team led by scientists from the Helmholtz Institute for RNA-based Infection Research (HIRI) has introduced a new ...

THEY look like ordinary foals, docile with honey brown coats and white facial patches, content to spend their days munching alfalfa in a cordoned-off pasture in rural Buenos Aires province.

PlantArcBio, an Israeli ag-biotech firm, has secured patents in the U.S. and South Korea for its DIPPER platform. This ...

Three centuries after vanishing from Earth, the famously ‘stupid’ dodo could be set for a bizarre comeback as scientists ...

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since ...

Shares of a Woburn biotech with hundreds of employees crashed on Thursday after the company announced that it does not expect ...

DIPPER™ platform accelerates development of drought-tolerant, high-yield, and resilient crops worldwide TEL AVIV, Israel, Sept. 18, 2025 /PRNewswire/ ...

Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing significant growth due to the rising awareness about the ...

CRISPR Therapeutics (NASDAQ:CRSP) traded higher in the premarket on Thursday after J.P. Morgan initiated its coverage with an Overweight recommendation, noting how the company stands out in the gene ...

The Tel Aviv-based company said the technology enhances the precision and efficiency of tools like CRISPR, accelerating the development of traits such as drought tolerance, yield improvement, and ...

Ace hedge fund manager Cathie Wood’s ARK Invest ETFs (exchange-traded funds) reported several notable trades for Wednesday, ...